Abstract
Although intravenous verapamil effectively terminates supraventricular tachycardia (SVT) in children, its utility as a chronic oral antidysrhythmic drug has been disappointing. To assess whether drug kinetics contribute to this problem, we measured serum concentrations before and for 24 hours after a maintenance oral dose of verapamil (mean dose 1.36 mg/kg, range 0.4-2.9 mg/kg) in 7 children with a median age of 10.8 yrs (range 2.8-15.3 yrs). All had SVT controlled by chronic oral verapamil at mean serum peak and trough concentrations of 248±117 and 64±38 ng/ml, respectively.
We found several clearly age-dependent kinetic parameters: younger children demonstrated faster drug uptake “Tmax” (p <.005), lower relative bioavailability “F” (p<.01), smaller volume of distribution “Vd” (p <.005) and slower elimination half-life “t ½ β” (p <.001). Younger children also exhibited a possible diurnal variation in drug kinetics. There was no significant age-relationship in distribution half-life “t½α” or drug clearance rate.
Although these changes have opposing effects on serum concentrations, their net effect in young children is for a greater dosage requirement, and perhaps a shorter dosage interval, than are currently recommended.
*Supported in part by G.D. Searle & Co. of Canada, Ltd., and the Ontario Heart and Stroke Foundation.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hesslein, P., Gow, R., D'Souza, J. et al. 376 AGE-DEPENDENT VERAPAMIL KINETICS AFFECT PEDIATRIC ORAL DOSE REQUIREMENTS. Pediatr Res 19, 173 (1985). https://doi.org/10.1203/00006450-198504000-00406
Issue Date:
DOI: https://doi.org/10.1203/00006450-198504000-00406